Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17

Avanthi Moodley, Abiodun Fatoba, Moses Okpeku, Thamsanqa Emmanuel Chiliza, Mthokozisi Blessing Cedric Simelane, Ofentse Jacob Pooe

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

Mycobacterium tuberculosis (Mtb) is responsible for high mortality rates in many low- and middle-income countries. This infectious disease remains accountable for around 1.4 million deaths yearly. Finding effective control measures against Mtb has become imperative. Vaccination has been regarded as the safe and lasting control measure to curtail the impact of Mtb. This study used the Mtb protein biomarker PE_PGRS17 to design a multi-epitope vaccine. A previous study predicted a strong antigenic property of PE_PGRS17. Immunogenic properties such as antigenicity, toxicity, and allergenicity were predicted for the PE_PGRS17 biomarker, specific B- and T-cell epitope sequences, and the final multiple epitope vaccine (MEV) construct. Algorithmic tools predicted the T- and B-cell epitopes and those that met the immunogenic properties were selected to construct the MEV candidate for predicted vaccine development. The epitopes were joined via linkers and an adjuvant was attached to the terminals of the entire vaccine construct. Immunogenic properties, and physicochemical and structural predictions gave insight into the MEV construct. The assembled vaccine candidate was docked with a receptor and validated using web-based tools. An immune simulation was performed to imitate the immune response after exposure to a dosed administrated predicted MEV subunit. An in silico cloning and codon optimisation gave insight into optimal expression conditions regarding the MEV candidate. In conclusion, the generated MEV construct may potentially emit both cellular and humoral responses which are vital in the development of a peptide-based vaccine against Mtb; nonetheless, further experimental validation is still required.

Original languageEnglish
Pages (from-to)501-517
Number of pages17
JournalImmunologic Research
Volume70
Issue number4
DOIs
Publication statusPublished - Aug 2022

Keywords

  • Biomarkers
  • Immunoinformatics
  • MEV candidate
  • T- and B-cells
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology

Fingerprint

Dive into the research topics of 'Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17'. Together they form a unique fingerprint.

Cite this